Company Update LUPIN LTD. - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Lupin and Zydus Sign Licensing Agreement for Co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India.